It was hypothesized that abnormal T2DM-connected brain glucose metabolism may lead to a decrease in O-GlcNAc levels, which results in neuroprotective mechanism failure and triggers a cascade of pathological forms of tau resulting in AD progression. The gene discussed is MAPT; the disease is Alzheimer disease.